UP!

News

Calithera Biosciences, Inc. -1.32% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-03-09 Future report Set alerts
Q3 2020 2020-11-11 Future report Set alerts
Q2 2020 2020-08-10 -0.29 -0.29
Q1 2020 2020-05-07 -0.38 -0.38
Q4 2019 2020-03-11 -0.39 -0.39
Q3 2019 2019-11-12 -0.38 -0.38
Q2 2019 2019-08-08 -0.58 -0.58
Q1 2019 2019-05-09 -0.61 -0.61
Q4 2018 2019-03-07 -0.51 -0.51
Q3 2018 2018-11-07 -0.52 -0.52

Ratings

2016-06-08 Reiterated Rating JMP Securities Buy
2016-05-12 Reiterated Rating Wells Fargo Buy
2016-05-12 Reiterated Rating Wells Fargo & Co. Buy
2016-03-09 Lower Price Target JMP Securities Market Outperform $20.00 to $12.00
2016-03-09 Lower Price Target JPMorgan Chase & Co. Market Outperform $20.00 to $12.00
2015-11-10 Lower Price Target Leerink Swann Outperform $19.00 to $13.00
2015-07-24 Initiated Coverage Citigroup Inc. Buy $11.00
2015-05-22 Reiterated Rating Leerink Swann Outperform $19.00
2015-01-28 Boost Price Target Citigroup Inc. Buy $15.00 to $30.00
2014-10-27 Initiated Coverage Citigroup Inc. Buy $15.00
2014-10-27 Initiated Coverage JMP Securities Outperform $20.00
2014-10-27 Initiated Coverage Wells Fargo & Co. Outperform
2014-10-27 Initiated Coverage Leerink Swann Outperform $13.00
2014-10-27 Initiated Coverage Wells Fargo Outperform
2016-06-08 Reiterated Rating JMP Securities Buy
2016-05-12 Reiterated Rating Wells Fargo Buy
2016-05-12 Reiterated Rating Wells Fargo & Co. Buy
2016-03-09 Lower Price Target JMP Securities Market Outperform $20.00 to $12.00
2016-03-09 Lower Price Target JPMorgan Chase & Co. Market Outperform $20.00 to $12.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks

Comments